LWAM
Legacy Wealth Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Sell |
1,416
-13
| -0.9% | -$5.79K | 0.16% | 202 |
|
|
2025
Q1 | $693K | Sell |
1,429
-22
| -2% | -$10.7K | 0.19% | 164 |
|
|
2024
Q4 | $584K | Sell |
1,451
-7
| -0.5% | -$2.82K | 0.16% | 206 |
|
|
2024
Q3 | $678K | Buy |
1,458
+12
| +0.8% | +$5.58K | 0.18% | 181 |
|
|
2024
Q2 | $678K | Sell |
1,446
-2,938
| -67% | -$1.38M | 0.19% | 154 |
|
|
2024
Q1 | $1.83M | Sell |
4,384
-8
| -0.2% | -$3.34K | 0.51% | 49 |
|
|
2023
Q4 | $1.79M | Sell |
4,392
-12
| -0.3% | -$4.88K | 0.59% | 45 |
|
|
2023
Q3 | $1.53M | Buy |
4,404
+17
| +0.4% | +$5.91K | 0.56% | 48 |
|
|
2023
Q2 | $1.54M | Buy |
4,387
+1,164
| +36% | +$410K | 0.54% | 45 |
|
|
2023
Q1 | $1.02M | Buy |
3,223
+8
| +0.2% | +$2.52K | 0.37% | 76 |
|
|
2022
Q4 | $928K | Buy |
3,215
+6
| +0.2% | +$1.73K | 0.35% | 85 |
|
|
2022
Q3 | $929K | Buy |
+3,209
| New | +$929K | 0.41% | 75 |
|